| |
Overview
HeadlinesNo recent Headlines for this stock. Business Background Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of novel therapeutic compounds for autoimmune and inflammatory diseases.
| |